What is Cytokinetics's PA — payments for tenant improvements?

Cytokinetics (CYTK) reported PA — payments for tenant improvements of $300K in Q4 2022.

What does PA — payments for tenant improvements mean?

Money spent to renovate or customize leased office or lab space.

How do you interpret PA — payments for tenant improvements?

Higher spending indicates significant investment in facility quality and operational capacity, which may drive future productivity.

How does PA — payments for tenant improvements compare across companies?

Common in companies with significant office or laboratory footprints requiring specialized build-outs.

Cytokinetics CYTK PA — Payments For Tenant Improvements

Discontinued — last reported Q4 '22

Similar metrics at other companies

CUBEPA — Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition

$3.22M+14.2%

TYLAppraisal And Tax — Payments For Capital Improvements

$825K-59.8%

REGPA — Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs

$13.89M+3.0%

OHIPA — Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements

$24.73M+27.4%

ARWRCalifornia — Payments for leasehold improvements, net of tenant improvement allowances

$32M+700%

PEA

PEAKPayments For Leasing Costs Commissions And Tenant Improvements

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForTenantImprovements.

The official record: Cytokinetics’s 10-K, filed March 1, 2023, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's pa — payments for tenant improvements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's PA — payments for tenant improvements?: Cytokinetics (CYTK) reported PA — payments for tenant improvements of $300K in Q4 2022.
What does PA — payments for tenant improvements mean?: Money spent to renovate or customize leased office or lab space.
How do you interpret PA — payments for tenant improvements?: Higher spending indicates significant investment in facility quality and operational capacity, which may drive future productivity.
How does PA — payments for tenant improvements compare across companies?: Common in companies with significant office or laboratory footprints requiring specialized build-outs.